Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Atyr Pharma Inc

Atyr Pharma Inc (LIFE)

Market is closed
News
aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcript

aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma fourth quarter and full year 2023 conference call. At this time, all participants are in a listen only mode.

Keep Reading →

March 15th, 2024 - News Transcripts

5 Most Promising Penny Stocks According to Analysts

5 Most Promising Penny Stocks According to Analysts

Germany-based Affimed N.V. (NASDAQ:AFMD) is working on cancer immunotherapies. Affimed N.V.

Keep Reading →

August 13th, 2023 - Hedge Funds News

aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

March 12th, 2023 - News Transcripts

aTyr Pharma, Inc. (NASDAQ:LIFE) Q3 2022 Earnings Call Transcript

aTyr Pharma, Inc. (NASDAQ:LIFE) Q3 2022 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen and welcome to aTyr Pharma's Third Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

December 29th, 2022 - News Transcripts

10 Best Pharma Stocks To Buy Now

10 Best Pharma Stocks To Buy Now

With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from $1454.7 billion in 2021.

Keep Reading →

October 24th, 2022 - Hedge Funds News

Hedge Fund and Insider Trading News: John Paulson, Michael Burry, Mike Novogratz, Paul Singer, Bluebell Capital Partners, Tiger Global Management, ExodusPoint Capital, Crowdstrike Holdings Inc (CRWD), aTyr Pharma Inc (LIFE), and More

Hedge Fund and Insider Trading News: John Paulson, Michael Burry, Mike Novogratz, Paul Singer, Bluebell Capital Partners, Tiger Global Management, ExodusPoint Capital, Crowdstrike Holdings Inc (CRWD), aTyr Pharma Inc (LIFE), and More

Billionaire crypto investor Mike Novogratz has said bitcoin holding firm at $40,000 during the recent sell-off is a good sign for the market, and recommended buying the dip in digital assets.

Keep Reading →

September 23rd, 2021 - Hedge Funds Insider Trading

aTyr Pharma Inc. (LIFE): Are Hedge Funds Right About This Stock?

aTyr Pharma Inc. (LIFE): Are Hedge Funds Right About This Stock?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.

Keep Reading →

June 30th, 2021 - Hedge Funds News

Is aTyr Pharma (LIFE) A Good Stock To Buy Now?

Is aTyr Pharma (LIFE) A Good Stock To Buy Now?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

December 2nd, 2020 - Hedge Funds News

Should You Buy aTyr Pharma Inc. (LIFE)?

Should You Buy aTyr Pharma Inc. (LIFE)?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

June 12th, 2020 - Hedge Funds News

13G Filing: Viking Global and aTyr Pharma Inc (LIFE)

13G Filing: Viking Global and aTyr Pharma Inc (LIFE)

aTyr Pharma Inc (NASDAQ:LIFE): Andreas Halvorsen's Viking Global filed an amended 13D. You can check out Viking Global's latest holdings and filings here.

Keep Reading →

September 12th, 2017 - Hedge Funds

Insider Monkey Quarterly Strategy
+246.9% Insider Monkey Quarterly Strategy
+107.5% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through Feb 16th, 2024)